ГОСТ ISO 10993-16-2016
their potential toxicity in the arthroplasty patient. A review of current knowledge
and future strategies, J. Bone Joint Surg. [Br], 89-B, pp. 567-573, 2007
[39] KIRMAN, C.R., SWEENEY, L.M., CORLEY, R. and GARGAS, M.L., Using
physiologically-based pharmacokinetic modeling to address nonlinear kinetics and
changes in rodent physiology and metabolism due to aging and adaptation in
deriving reference values for propylene glycol methyl ether and propylene glycol
methyl ether acetate,Risk Anal.,25, pp. 271-284,2005
[40] KRISHNAN, K. and JOHANSON, G., Physiologically-based pharmacokinetic and
toxicokinetic models in cancer risk assessment, J. Environ. Sci. Health, Part C:
Environ. Carcinogen. Ecotox. Rev., 23, pp. 31-53,2005
[41] LEWIS, D.F.V. and DICKINS, M., Baseline lipophilicity relationships in human
cytochromes P450 associated with drug metabolism, Drug Metab. Revs., 35, pp. 1-
18,2003
[42] LINHART, I., Stereochemistry of styrene biotransformation. Drug Metab. Revs.,
33, pp. 353-368, 2001
[43] LUU,H.M.L., HUTTER, J.C.andBUSHAR, A.,Physiologically based
pharmacokinetic model (PBPK) model for 2,4-toluenediamine leached from
polyurethane foam-covered breast implants, Envir. Health Perspectives 106(7),
pp. 393-400,1998
[44] MAHMOOD.I., GREEN, M.D. and FISHER, J.E., Selection of the first-time dose
in humans: comparison of different approaches based on interspecies scaling of
clearance, J. Clin. Pharmacol., 43, pp. 692-697,2003
[45] MEEK, B., RENWICK, A. and SONICH-MULLIN, C.. International Programme on
Chemical Safety: Practical application of kinetic data in risk assessment — an
IPCS initiative. Toxicol. Lett., 138, pp. 151-60,2003
[46] MIZUTANI, T., PM frequencies of major CYPs in Asians and Caucasians, Drug
Metab. Revs., 35, pp. 99-107,2003
[47] NESTOROV, I., Whole Body Pharmacokinetic Models: Review Article, Clin.
Pharmacokin., 42, pp. 883-908, 2003
[48] OECD Guideline for Testing of Chemicals, 417: Toxicokinetics, Adopted: 4 April
1984
[49] ORN,U.andKLASSON-WEHLER, E,Metabolismof 2, 2’,4, 4’-
tetrabromodiphenylether in rat and mouse, Xenobiotica,28, pp. 199-211,1998
[50] POULIN, P. and THEIL, F-P., Prediction of pharmacokinetics prior to In Vivo
IS